GLOW Blend (GHK-Cu + BPC-157 + TB-500) — Research Material
GLOW Blend —
GHK-Cu + BPC-157
+ TB-500
GLOW is a co-lyophilized research blend of GHK-Cu (50 mg), BPC-157 (10 mg) and TB-500 (10 mg). HPLC-verified at ≥99% purity with a batch-specific certificate of analysis on every lot.
Per vial, with 20% Fall Sale discount already applied.
Choose quantity
View the 70 MG lab certificate (PDF)What is in the GLOW blend
GLOW is a triple-peptide research blend — GHK-Cu, BPC-157 and TB-500 — co-lyophilized in a single 70 mg vial at 50 mg, 10 mg and 10 mg respectively.
The three components are structurally unrelated and are normally studied separately. GHK-Cu is a copper-binding tripeptide; BPC-157 is a 15-amino-acid sequence derived from a protein found in gastric juice; TB-500 is a thymosin β4 peptide (CAS 77591-33-4), associated with actin binding. They are supplied as a blend rather than as a single molecule.
Co-lyophilisation matters practically: all three peptides reconstitute from one vial in one step, so the ratio between them is fixed at manufacture rather than by pipetting three separate stocks. Nothing on this page should be read as a claim that the combination produces any particular result.
Blend components
GHK-Cu
A copper-binding tripeptide (glycyl-L-histidyl-L-lysine complexed with copper(II)). CAS 89030-95-5. Supplied here at 50 mg per vial, HPLC-verified to ≥99%. It is the largest component of the blend by mass.
BPC-157
A 15-amino-acid peptide (a pentadecapeptide) derived from a sequence identified in gastric juice. CAS 137525-51-0. Supplied here at 10 mg per vial, HPLC-verified to ≥99%.
TB-500
A thymosin β4 peptide, CAS 77591-33-4, associated with actin binding. Supplied here at 10 mg per vial, HPLC-verified to ≥99%.
GLOW: published literature
The references below concern the individual components, not this blend. All three peptides have been studied principally in laboratory and animal models; none is an approved drug, and the GHK-Cu + BPC-157 + TB-500 combination has not been evaluated as a combination in published clinical trials. They are cited as literature — APEX 100 Research makes no claim about outcomes, efficacy or suitability for any purpose.
Buy GLOW (GHK-Cu + BPC-157 + TB-500)
Volume pricing applies automatically at checkout.
Prices shown include the 20% Fall Sale discount.
Common questions
What is in the GLOW blend?
One 70 mg vial containing GHK-Cu (50 mg), BPC-157 (10 mg) and TB-500 (10 mg), co-lyophilized
together. Catalogue SKU A100-BBG70.
What does ≥99% HPLC purity mean?
High-performance liquid chromatography separates the sample into its components and measures each as a proportion of the total. ≥99% means the target peptide accounts for at least 99% of the material by that method. The chromatogram showing this is included in the lot’s COA.
Can I see the COA before ordering?
Yes. Sample documentation is on our COA page, and we will send the specific COA for any lot on request — before or after purchase.
Is this a drug product?
No. This material is supplied strictly as a research material. It is not a drug product and is not for human consumption.
How is this shipped?
Sourced and shipped within the United States, typically 2-day delivery. Lyophilized peptides are stable in transit; refrigerate on arrival.
Why are both peptides in one vial?
They are co-lyophilized, so the 10 mg : 10 mg ratio is fixed at manufacture and both reconstitute in a single step. It removes the pipetting error involved in combining two separate stocks.
GLOW Purity & COA
Every lot is tested before release and ships with its own certificate of analysis. We publish the COA unredacted — including the lot number, the test date and the actual chromatogram — rather than a summary figure.
HPLC purity
High-performance liquid chromatography establishes purity against the ≥99% specification. The chromatogram is included in the COA, not just the resulting number.
Mass spectrometry
Identity is confirmed by mass spectrometry against the expected molecular weight of each component (GHK-Cu 340.384 g/mol, BPC-157 1419.556 g/mol, TB-500 4963 g/mol).
Lot traceability
Each vial’s lot number corresponds to a specific COA on file. Request the document for any lot you have received at any time.
GLOW Specifications
| Blend | GLOW — GHK-Cu 50 mg + BPC-157 10 mg + TB-500 10 mg, co-lyophilized (70 mg total) |
|---|---|
| Component 1 | GHK-Cu — copper tripeptide, 3 amino acids (Gly-His-Lys) complexed with copper(II) |
| GHK-Cu CAS | 89030-95-5 |
| GHK-Cu formula | C14H24N6O4 |
| GHK-Cu molecular weight | 340.384 g/mol |
| Component 2 | BPC-157 — pentadecapeptide, 15 amino acids |
| BPC-157 CAS | 137525-51-0 |
| BPC-157 formula | C62H98N16O22 |
| BPC-157 molecular weight | 1419.556 g/mol |
| Component 3 | TB-500 — thymosin β4 peptide |
| TB-500 formula | C212H350N56O78S |
| TB-500 molecular weight | 4963 g/mol |
| TB-500 CAS | 77591-33-4 |
| Physical form | Lyophilized powder, white to off-white |
| Purity | ≥99% by HPLC, per component |
| Identity confirmation | Mass spectrometry |
| Vial size | 70 mg (SKU A100-BBG70) |
| Storage | Lyophilized: 36–46 °F. Long term: −4 °F, protected from light |
| Documentation | Batch-specific COA, unredacted, retained on file per lot |
Handling and storage
Supplied lyophilized. Standard laboratory handling for peptides of this class applies.
| Lyophilized storage | 36–46 °F short term; −4 °F for extended storage, protected from light |
|---|---|
| Reconstitution | Bacteriostatic water is the common choice for laboratory reconstitution. Add solvent slowly against the vial wall; do not inject directly onto the powder. |
| Mixing | Swirl gently until dissolved. Do not shake or vortex — mechanical agitation can shear peptide chains. |
| After reconstitution | Refrigerate at 36–46 °F. Avoid repeated freeze-thaw cycles. |
| Light | Protect from light at all stages. |
These are general laboratory handling notes for a lyophilized peptide. They are not a protocol, and nothing on this page constitutes a dosing recommendation of any kind.
Research use only. Not for human consumption.
All materials supplied by APEX 100 Research are intended exclusively for laboratory research by qualified professionals. They are not drugs, foods, cosmetics, or medical devices, and they are not intended to diagnose, treat, cure or prevent any disease or condition.
Nothing on this page is medical advice, a dosing recommendation, or a representation that this compound is safe or effective for any purpose. GLOW and its individual components are investigational materials that have not been approved for any use by the FDA or any comparable regulatory authority. Peer-reviewed publications are referenced above so researchers may consult the primary literature directly; their citation is not a claim about this material.
By purchasing, the buyer confirms they are a qualified researcher, are 21 years of age or older, and accept full responsibility for lawful handling, storage and use of the material.
